documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
23 rows where docket_id = "FDA-2019-N-5900" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 3
agency_id 1
- FDA 23
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2019-N-5900-0030 | FDA | None FDA-2019-N-5900 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals | Notice | Notice of Approval | 2021-03-26T04:00:00Z | 2021 | 3 | 2021-03-26T04:00:00Z | 2021-03-26T14:32:35Z | 2021-06266 | 0 | 0 | 0900006484a7ec9c | |
| FDA-2019-N-5900-0028 | FDA | None FDA-2019-N-5900 | Ref 16 - BisawsBiswas&Das2006 celeb expert RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion | Supporting & Related Material | Background Material | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T17:07:12Z | 0 | 0 | 0900006484998e6f | |||
| FDA-2019-N-5900-0027 | FDA | None FDA-2019-N-5900 | Ref 15 - Till&Busler2000_match up hyp RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion | Supporting & Related Material | Background Material | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T17:07:04Z | 0 | 0 | 0900006484998e6e | |||
| FDA-2019-N-5900-0019 | FDA | None FDA-2019-N-5900 | Ref 7 - U.S._ Average age of Instagram users _ Statista RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion | Supporting & Related Material | Background Material | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T17:05:45Z | 0 | 0 | 0900006484998e66 | |||
| FDA-2019-N-5900-0024 | FDA | None FDA-2019-N-5900 | Ref 12 - Brown&Bocarnea2007 RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion | Supporting & Related Material | Background Material | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T17:06:27Z | 0 | 0 | 0900006484998e6b | |||
| FDA-2019-N-5900-0014 | FDA | None FDA-2019-N-5900 | Ref 1 - LaTour&Smith1986 RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion | Supporting & Related Material | Background Material | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T17:04:57Z | 0 | 0 | 0900006484998962 | |||
| FDA-2019-N-5900-0016 | FDA | None FDA-2019-N-5900 | Ref 3 - Boerman et al 2017 sponsored posts FB RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion | Supporting & Related Material | Background Material | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T17:05:20Z | 0 | 0 | 0900006484998964 | |||
| FDA-2019-N-5900-0017 | FDA | None FDA-2019-N-5900 | Ref 5 - Faul2007_Article_GPower3AFlexibleStatisticalPow RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion | Supporting & Related Material | Background Material | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T17:05:30Z | 0 | 0 | 0900006484998e64 | |||
| FDA-2019-N-5900-0015 | FDA | None FDA-2019-N-5900 | Ref 2 - Bhutada Rollins 2015 RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion | Supporting & Related Material | Background Material | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T17:05:12Z | 0 | 0 | 0900006484998963 | |||
| FDA-2019-N-5900-0022 | FDA | None FDA-2019-N-5900 | Ref10 - Kamins and Gupta.Robins RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion | Supporting & Related Material | Background Material | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T17:06:12Z | 0 | 0 | 0900006484998e69 | |||
| FDA-2019-N-5900-0023 | FDA | None FDA-2019-N-5900 | Ref 11 - PhuaLin&Lim2018 RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion | Supporting & Related Material | Background Material | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T17:06:19Z | 0 | 0 | 0900006484998e6a | |||
| FDA-2019-N-5900-0021 | FDA | None FDA-2019-N-5900 | Ref 9 - Ohanian1991 intent RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion | Supporting & Related Material | Background Material | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T17:06:02Z | 0 | 0 | 0900006484998e68 | |||
| FDA-2019-N-5900-0026 | FDA | None FDA-2019-N-5900 | Ref 14 - HuhDeLormeReid2004 RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion | Supporting & Related Material | Background Material | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T17:06:57Z | 0 | 0 | 0900006484998e6d | |||
| FDA-2019-N-5900-0018 | FDA | None FDA-2019-N-5900 | Ref 6. - Woods et al (2017) RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion | Supporting & Related Material | Background Material | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T17:05:38Z | 0 | 0 | 0900006484998e65 | |||
| FDA-2019-N-5900-0020 | FDA | None FDA-2019-N-5900 | Ref 8 - Zaichowsky1994 RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion | Supporting & Related Material | Background Material | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T17:05:52Z | 0 | 0 | 0900006484998e67 | |||
| FDA-2019-N-5900-0025 | FDA | None FDA-2019-N-5900 | Ref 13 - Brown&Matviuk2010 RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion | Supporting & Related Material | Background Material | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T17:06:34Z | 0 | 0 | 0900006484998e6c | |||
| FDA-2019-N-5900-0029 | FDA | None FDA-2019-N-5900 | Ref 17 - Bocarnea&Brown2007 RE Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion | Supporting & Related Material | Background Material | 2020-12-11T05:00:00Z | 2020 | 12 | 2020-12-11T17:07:19Z | 0 | 0 | 0900006484998e70 | |||
| FDA-2019-N-5900-0012 | FDA | None FDA-2019-N-5900 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Directto-Consumer Promotion | Notice | 30 Day Proposed Information Collection | 2020-12-07T05:00:00Z | 2020 | 12 | 2020-12-07T05:00:00Z | 2021-01-07T04:59:59Z | 2020-12-08T02:00:52Z | 2020-26799 | 0 | 0 | 0900006484989f3f |
| FDA-2019-N-5900-0009 | FDA | None FDA-2019-N-5900 | Request for Extension from Academy, Ltd. d/b/a Academy Sports + Outdoors | Other | Request for Extension | 2020-04-01T04:00:00Z | 2020 | 4 | 2020-04-01T04:00:00Z | 2020-04-01T15:00:18Z | 0 | 0 | 090000648447893c | ||
| FDA-2019-N-5900-0004 | FDA | None FDA-2019-N-5900 | A Study of Expert Endorsement of OTC Pharmaceutical Products LaTour&Smith1986 RE: Agency Information Collection Activities; Proposed Collection; Comment Request; Endorser Status and Explicitness of Payment in Direct-to- Consumer Promotion | Supporting & Related Material | Background Material | 2020-01-28T05:00:00Z | 2020 | 1 | 2020-01-28T18:32:19Z | 0 | 0 | 09000064842fd532 | |||
| FDA-2019-N-5900-0002 | FDA | None FDA-2019-N-5900 | "This Post Is Sponsored” Effects of Sponsorship Disclosure on Persuasion Knowledge and Electronic Word of Mouth in the Context of Facebook RE: Agency Information Collection Activities; Proposed Collection; Comment Request; Endorser Status and Explicitness of Payment in Direct-to- Consumer Promotion | Supporting & Related Material | Background Material | 2020-01-28T05:00:00Z | 2020 | 1 | 2020-01-28T18:37:17Z | 0 | 0 | 09000064842fd530 | |||
| FDA-2019-N-5900-0001 | FDA | None FDA-2019-N-5900 | Agency Information Collection Activities; Proposed Collection; Comment Request; Endorser Status and Explicitness of Payment in Direct-to- Consumer Promotion | Notice | 60 Day Proposed Information Collection | 2020-01-28T05:00:00Z | 2020 | 1 | 2020-01-28T05:00:00Z | 2020-03-31T03:59:59Z | 2020-04-02T01:02:51Z | 2020-01408 | 0 | 0 | 09000064842faa38 |
| FDA-2019-N-5900-0003 | FDA | None FDA-2019-N-5900 | Disease-specific direct-to-consumer advertising of pharmaceuticals: An examination of endorser type and gender effects on consumers’ attitudes and behaviors Nilesh S. Bhutada, Ph.D.a, Brent L. Rollins, R.Ph., Ph.D.b,* RE: Agency Information Collection Activities; Proposed Collection; Comment Request; Endorser Status and Explicitness of Payment in Direct-to- Consumer Promotion | Supporting & Related Material | Background Material | 2020-01-28T05:00:00Z | 2020 | 1 | 2020-01-28T18:32:11Z | 0 | 0 | 09000064842fd531 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;